GLOBULIN COMPONENT MACROPHAGE ACTIVATING FACTOR (GcMAF)

Interview with CEO David Noakes 9-2015

For more information please visit - https://gcmaf.se/ All healthy people have natural GcMAF inside them – it removes a number of diseases from the body including cancer without side effects. The immune system doesn’t function without it The GcMAF in our bodies has six attacks on cancer and 5 other direct effects that research publications have shown so far. Without the GcMAF we make inside us every day, we would all have died of diseases while still children. Serious illnesses like cancer, and many others listed on our website, prevent the production of your GcMAF, which also neutralises your immune system, so the disease can grow unchecked.

Directed Immune System Natural Therapies and Diagnostic Testing. A clinical presentation about GcMAF and how it works to kill cancer.

Tutorial on making GcMAF at home for a fraction of the cost. Please subscribe to our channel for more future videos and valuable information.

GcMAF eradicates cancer; cells seen via microscopes and time lapse photography. This is a world wide first, and a scientific research paper named "Multifaceted immunotherapeutic effects of GcMAF on human breast cancer cells" peer reviewed, and published by us in the January 2013 Immunology Conference in San Diego. Human MCF7 breast cancer cells are shown both in a corrugated layer on the surface below, and as irregular "fingers" above. Macrophages are small round circles added at the bottom left. They do nothing until the First Immune GcMAF is added. Time lapse photography over 60 hours shows the cancer monolayer below first changing from corrugated to smooth from the bottom left as the cancer is destroyed; then the cancer "fingers" are also eaten and destroyed by the macrophages. This is part of the assays performed on batches of our GcMAF, and are carried out in First Immune (gcmaf.eu's) laboratories as part of our everyday production. We supply 5,000 patients, 300 doctors in 30 nations. This confirms the research paper "Effects of vitamin D-binding protein-derived macrophage-activating factor on human breast cancer cells," published in the journal Anticancer Research 2012 Jan;32(1):45-52, in which they also kindly used our First Immune GcMAF for their experiments.